Patent US5068112A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5068112A Expired / Lapsed US ⏱️ 0.0 years remaining

Controlled release pharmaceutical preparation and method for producing the same

Assignee: Tanabe Pharma Corp
•
Filing: 1989-03-24
•
Granted: 1991-11-26
•
Expires: 2009-03-24
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Disclosed is a controlled release pharmaceutical preparation, comprising a core containing a pharmaceutically active ingredient, and a porous film of a hydrophobic polymeric substance or a hydrophobic polymeric substance and a hydrophilic polymeric substance, the core being coated with the porous film. Disclosed is also a method for producing the same. The controlled release pharmaceutical preparation of this invention posseses a desired dissolution rate by controlling the porosity of the porous film.

Inventors

  • 👤 Masayoshi Samejima
  • 👤 Kazuo Noda
  • 👤 Yoshiyuki Hirakawa
  • 👤 Hiroyuki Yoshino

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-30 10:42
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/14; A61K9/16; A61K9/48; A61K9/50; A61K9/5073; A61K9/5078; A61K9/20; A61K9/28; A61K9/2806; A61K9/2833; A61K9/286; A61K9/2866

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 66 words
A controlled release pharmaceutical preparation comprising: (A) a core containing a pharmaceutically active ingredient and succinic acid; and (B) a porous cellulose film formed on the surface of said core by spraying a water-organic solvent mixture containing ethyl cellulose or a mixture of ethyl cellulose and hydroxypropyl cellulose, said porous cellulose film having a porosity of about 0.4 to 0.9 calculated according to the formula: ##EQU2##
Claim 2
Dependent Claim 66 words
A controlled release pharmaceutical preparation comprising: (A) a core containing a pharmaceutically active ingredient and succinic acid; and (B) a porous cellulose film formed on the surface of said core by spraying a water-organic solvent mixture containing ethyl cellulose or a mixture of ethyl cellulose and hydroxypropyl cellulose, said porous cellulose film having a porosity of about 0.4 to 0.9 calculated according to the formula: ##EQU2##
Claim 3
Dependent Claim 18 words
The preparation according to claim 1, wherein said porous film has a porosity of about 0.5 to 0.85.
Claim 4
Dependent Claim 13 words
The preparation according to claim 1, wherein said porous film comprises ethyl cellulose.
Claim 5
Dependent Claim 16 words
The preparation according to claim 1, wherein said porous film comprises ethyl cellulose and hydroxypropyl cellulose.
Claim 6
Dependent Claim 30 words
The preparation according to claim 4, wherein said porous film comprises 0.05 to 0.5 part by weight of said hydroxypropyl cellulose per 1 part by weight of said ethyl cellulose.
Claim 7
Independent Claim 69 words
A method of producing a controlled release pharmaceutical preparation which comprises spray-coating a water-organic solvent mixture containing ethyl cellulose or a mixture of ethyl cellulose and hydroxypropyl cellulose onto the surface of a core containing a pharmaceutically active ingredient and succinic acid to produce a porous cellulose film on said core, said porous cellulose film having a porosity of about 0.4 to 0.9 calculated according to the formula: ##EQU3##
Claim 8
Independent Claim 69 words
A method of producing a controlled release pharmaceutical preparation which comprises spray-coating a water-organic solvent mixture containing ethyl cellulose or a mixture of ethyl cellulose and hydroxypropyl cellulose onto the surface of a core containing a pharmaceutically active ingredient and succinic acid to produce a porous cellulose film on said core, said porous cellulose film having a porosity of about 0.4 to 0.9 calculated according to the formula: ##EQU3##

References Cited (Backward Citations)

EP0148811A1 Cited
US4666702A Cited
US4769027A Cited
US4629619A Cited
US4663147A Cited
US4832958A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1994-11-25 1995-05-27 1995-11-26 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1998-11-25 1999-05-27 1999-11-26 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2002-11-25 2003-05-27 2003-11-26 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag